Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-05-29
2007-05-29
Crouch, Deborah (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100
Reexamination Certificate
active
10478449
ABSTRACT:
The invention provides a vector which is capable of the expression of a vascular endothelial growth factor wherein the vector comprises a modified PCMV promoter. The invention further provides use of a vector which is capable of and expressing a vascular endothelial growth factor (VEGF) for the regulation of endothelial function, angiogenesis and arteriogenesis. The invention further comprises use of a vector which is capable of the expression of a vascular endothelial growth factor (VEGF) for the prophylactic treatment of arterial diseases and/or bone marrow diseases and/or neural diseases.
REFERENCES:
patent: 5830879 (1998-11-01), Isner
patent: 5919652 (1999-07-01), Pang et al.
patent: 0 561 034 (1993-09-01), None
patent: WO 9947690 (1999-09-01), None
patent: WO 0061751 (2000-10-01), None
Baumgartner et al, Circulation, 97:1114-1123, 1998.
Neufeld et al, FASEB Journal, 13:9-22, 1999.
Daniel et al, Plant Molecular Biology, 28:821-836, 1995. Abstract only.
Isner et al, Lancet, 348:370-374, 1996.
Schaper et al, Cardiovascular Research, 43:835-837, 1999.
Schwartz et al, Gene Therapy, 3:405-411, 1996.
Dente et al, Nucleic Acids Research, 11:1645-1655, 1983.
Yla-Herttuala, Lancet, 355:213-222, 2000.
Gardlik et al, Medical Science Monitor, 11:RA110-RA121, 2005.
Romano et al, Stem Cells, 18: 19-39, 2000.
Romano Drug News Perspect, 17(2): 85-90, 2004.
Database EMBL Online, retrieved from EBI, Database Accession No. AF264696, XP002180574.
Database EMBL Online, retrieved from EBI, Database Accession No. U47120, XP002180575.
Roossien Folkert Feiko
Ubink-Bontekoe Carola Jacoba M.
Visser Tjerk Johannes A.
Amster Rothstein & Ebenstein LLP
Crouch Deborah
Fornix Biosciences N.V.
Sgagias Magdalene
LandOfFree
Vectors for enhanced expression of VEGF for atrial disease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vectors for enhanced expression of VEGF for atrial disease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors for enhanced expression of VEGF for atrial disease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3720772